[Present and future of simvastatin: new questions for the third millennium].
Mercuri
M
M
Dipartimento di Endocrinologia e Metabolismo Merck & Co Inc, 126, Lincoln Avenue, Rahway, NJ 07065-0900, USA. michele_mercuri@merck.com
D005544:Forecasting; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D019821:Simvastatin / Q000627:therapeutic use*
D000960:Hypolipidemic Agents; D019821:Simvastatin